Hyoscine butylbromide (Buscopan) injection: risk of serious adverse effects in patients with underlying cardiac disease

Source:
GOV UK
Publisher:
Medicines and Healthcare products Regulatory Agency
Publication date:
20 February 2017

Abstract

Prescribing information has been updated to help to minimise the risk of serious adverse reactions in patients with cardiac disease.